Skip to content

Insider · CIK 0001200889

James W McCollum

director

Files at LENZ (LENZ Therapeutics, Inc.). First filing Nov 10, 2025, latest Nov 10, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$239k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

LENZ: LENZ Therapeutics, Inc.

LENZOct 9, 2026 · close 3.64

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
44Moderate
LENZbuy 2
LENZ Therapeutics, Inc.
$239k
10,500 shares
--

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 7, 2025LENZ
LENZ Therapeutics, Inc.
POpen-market purchase
Common Stock
+10,500$22.79$239k10,500Nov 10, 2025
Jun 11, 2025LENZ
LENZ Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+13,500$0.00$013,500Jun 11, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

James W McCollum: insider trades and track record | InsiderTell